Case-mix adjustment approach to benchmarking prevalence rates of nosocomial infection in hospitals in Cyprus and Greece

Infection Control and Hospital Epidemiology

Volumn 29, Issue 8, 2008, Pages 685-692

  Kritsotakis, Evangelos I ^a   Dimitriadis, Ioannis ^f   Roumbelaki, Maria ^b   Vounou, Emelia ^g   Kontou, Maria ^h   Papakyriakou, Panikos ⁱ   Koliou Mazeri, Maria ^j   Varthalitis, Ioannis ^c   Vrouchos, George ^d   Troulakis, George ^e   Gikas, Achilleas ^a,b  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^c Chania General Hospital St George   (Greece)

^d Venizelion General Hospital   (Greece)

^e General Hospital of Agios Nikolaos   (Greece)

^f Larnaca General Hospital   (Cyprus)

^g LIMASSOL GENERAL HOSPITAL   (Cyprus)

^h NICOSIA GENERAL HOSPITAL   (Cyprus)

ⁱ General Hospital of Pafos   (Cyprus)

^j Archbishop Makarios Hospital of Nicosia   (Cyprus)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; GLYCOPEPTIDE; IMIDAZOLE DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE;

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONTROLLED STUDY; CYPRUS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GREECE; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFECTION RATE; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; QUALITY CONTROL; RISK FACTOR;

AGED; ANTI-BACTERIAL AGENTS; CROSS INFECTION; CROSS-SECTIONAL STUDIES; CYPRUS; FEMALE; GREECE; HOSPITAL BED CAPACITY; HOSPITALS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK ADJUSTMENT; RISK FACTORS;

EID: 50949103761     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/588704     Document Type: Article

References (34)

1. Burke JP. Infection control - a problem for patient safety. N Engl J Med 2003;348:651-656.
2. Gaynes R, Richards C, Edwards J, et al. Feeding back surveillance data to prevent hospital-acquired infections. Emerg Infect Dis 2001;7:295-298.
3. Humphreys H, Smyth ET. Prevalence surveys of healthcare-associated infections: what do they tell us, if anything? Clin Microbiol Infect 2006;12:2-4.
4. Richardson D, Tarnow-Mordi WO, Lee SK. Risk adjustment for quality improvement. Pediatrics 1999;103(suppl E):255-265.
5. Pittet D, Harbarth S, Ruef C, et al. Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland. Infect Control Hosp Epidemiol 1999;20:37-42.
6. Sax H, Pittet D; Swiss-NOSO Network. Interhospital differences in nosocomial infection rates: importance of case-mix adjustment. Arch Intern Med 2002;162:2437-2442.
7. Sartor C, Delchambre A, Pascal L, Drancourt M, De Micco P, Sambuc R. Assessment of the value of repeated point-prevalence surveys for analyzing the trend in nosocomial infections. Infect Control Hosp Epidemiol 2005;26:369-373.
8. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. 2nd ed. Geneva: World Health Organization; 2006.
9. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale: an examination of its reliability and validity in a research setting. Cancer 1984;53:2002-2007.
10. Needham DM, Scales DC, Laupacis A, Pronovost PJ. A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care 2005;20:12-19.
11. McCabe WR, Jackson GG. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962;110:847-855.
12. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, ed. Hospital Epidemiology and Infection Control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004:1659-1702.
13. Hosmer D, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: Wiley; 2000.
14. Kahn HA, Sempos CT. Statistical Methods in Epidemiology. New York: Oxford University Press; 1989.
15. Reilly J, Stewart S, Allardice, et al. Health Protection Scotland. NHS Scotland National Hospital Acquired Infection Prevalence Survey. Final Report 2007. Available at: http://www.hps.scot.nhs.uk/haiic/sshaip/publications/ national-prevalence-study/report/full-report.pdf. Accessed January 30, 2007.
16. Emmerson AM, Enstone JE, Griffin M, Kelsey MC, Smyth ET. The Second National Prevalence Survey of infection in hospitals - overview of the results. J Hosp Infect 1996;32:175-190.
17. Christensen M, Jepsen OB. Reduced rates of hospital-acquired UTI in medical patients: prevalence surveys indicate effect of active infection control programmes. J Hosp Infect 2001;47:36-40.
18. Zotti CM, Messori Ioli G, Charrier L, et al. Hospital-acquired infections in Italy: a region wide prevalence study. J Hosp Infect 2004;56:142-149.
19. Vaqué J, Rosselló J, Arribas JL. Prevalence of nosocomial infections in Spain: EPINE study 1990-1997. EPINE Working Group. J Hosp Infect 1999;43(Suppl):105-111.
20. The French Prevalence Survey Study Group. Prevalence of nosocomial infections in France: results of the nationwide survey in 1996. J Hosp Infect 2000;46:186-193.
21. Eriksen HM, Iversen BG, Aavitsland P. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. J Hosp Infect 2005;60:40-45.
22. Klavs I, Bufon Luznik T, Skerl M, et al. Prevalance of and risk factors for hospital-acquired infections in Slovenia - results of the first national survey, 2001. J Hosp Infect 2003;54:149-157.
23. Gastmeier P, Kampf G, Wischnewski N, et al. Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect 1998;38:37-49.
24. Ruef C. Prevalence of nosocomial infections - who knows the true rates? Infection 1997;25:203-205.
25. Floret N, Bailly P, Bertrand X, et al. Results from a four-year study on the prevalence of nosocomial infections in Franche-Comté: attempt to rank the risk of nosocomial infection. J Hosp Infect 2006;63:393-398.
26. Dodek P, Keenan S, Cook D, et al. Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med 2004;141:305-313.
27. Gikas A, Pediaditis J, Papadakis JA, et al. Prevalence study of hospital-acquired infections in 14 Greek hospitals: planning from the local to the national surveillance level. J Hosp Infect 2002;50:269-275.
28. Gikas A, Roumbelaki M, Pediaditis J, et al. Prevalence of nosocomial infections after surgery in Greek hospitals: results of two nationwide surveys. Infect Control Hosp Epidemiol 2004;25:319-324.
29. Kritsotakis EI, Assithianakis P, Kanellos P, Tzagarakis N, Ioannides MC, Gikas A. Surveillance of monthly antimicrobial consumption rates stratified by patient-care area: a tool for triggering and targeting antibiotic policy changes in the hospital. J Chemother 2006;18:394-401.
30. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999;27:97-132.
31. Rello J. Impact of nosocomial infections on outcome: myths and evidence. Infect Control Hosp Epidemiol 1999;20:392-394.
32. Norena M, Wong H, Thompson WD, Keenan SP, Dodek PM. Adjustment of intensive care unit outcomes for severity of illness and comorbidity scores. J Crit Care 2006;21:142-150.
33. Gaynes RP. Surgical-site infections (SSI) and the NNIS Basic SSI Risk Index, part II: room for improvement. Infect Control Hosp Epidemiol 2001;22:266-267.
34. Gastmeier P, Sohr D, Rath A, et al. Repeated prevalence investigations on nosocomial infections for continuous surveillance. J Hosp Infect 2000;45:47-53.